Mounjaro weight loss slowed down — what's actually happening

The myth that a stall means Mounjaro has stopped working

This is the question our prescribers hear most weeks, usually framed with a note of defeat: "I was losing steadily, and now nothing for three weeks, has it stopped working?" The short answer is almost certainly no. The scales stalling is not the same as treatment failing. Tirzepatide, the active ingredient in Mounjaro, keeps activating the GIP and GLP-1 receptors involved in appetite regulation and blood-glucose control throughout treatment. What changes is your body's energy balance.

When you lose a meaningful amount of weight, your resting metabolic rate drops. A lighter body requires fewer calories to function. That is not a flaw in the medicine; it is human physiology doing exactly what it evolved to do. The SURMOUNT-1 trial, published in the New England Journal of Medicine, showed average losses of around 20–21% of body weight at the highest dose over 72 weeks, but that trajectory was not a straight line downward. Periods of slower progress appeared throughout, which is why the trial ran for well over a year. A three-week plateau in month four is consistent with how the medicine behaves in real-world use, not a red flag.

There is also a psychological dimension worth naming. Early losses, often driven by the rapid appetite suppression at lower doses, feel dramatic precisely because they are front-loaded. When the rate normalises, the contrast feels alarming even if the total progress is substantial. If you are finding this experience frustrating, that is understandable. It is a very common point at which people wonder whether to stop, and usually the wrong moment to do so.

Why weight loss slows down at a specific dose of Mounjaro

Mounjaro's titration schedule starts at 2.5 mg. That dose exists to let your system adjust, not to produce the maximum fat loss. As the dose increases through 5, 7.5, 10 and 12.5 mg toward the maximum 15 mg, appetite suppression and metabolic effects typically strengthen. If you have noticed your weight loss slowing down on Mounjaro at your current dose, it may mean you are approaching the limit of what that dose can do for your particular physiology, rather than the limit of what the medicine can do overall.

This is why the prescribing framework allows titration. If you have been at a given dose for several weeks, have tolerated it well, and progress has stalled, a review with your prescriber is the appropriate next step, not stopping treatment. The NHS patient information on tirzepatide is clear that dosing decisions sit entirely with the prescriber; self-adjusting is not safe or appropriate.

For a broader view of how weight loss typically progresses on tirzepatide, the Mounjaro weight loss overview covers the full trajectory. And if the question of why progress slows at a particular phase is something you want to understand more deeply, there is more detail at does weight loss slow down on Mounjaro.

What tends to stall progress, and what actually helps

Treatment does not exist in isolation. Several factors outside the medicine itself can slow things down, and if you want to understand in more detail why weight loss has slowed on Mounjaro, the answer is often a combination of the biology above and one or two of the following.

Calorie creep. Mounjaro reduces hunger significantly, but it does not eliminate appetite entirely. Over time, people sometimes eat slightly more than they realise, particularly if portions have drifted back toward pre-treatment habits. Tracking food intake for a week is often enough to reveal whether this is a factor.

Protein and muscle mass. Rapid weight loss without adequate protein can erode muscle. Muscle tissue burns more calories at rest than fat tissue, so losing it accelerates the metabolic slowdown that slows your weight loss further. Most adults on GLP-1 treatment benefit from prioritising protein at each meal, though the specific target depends on your individual plan, a dietitian can advise precisely.

Sleep and stress. Both affect the hormones that regulate appetite and fat storage. Neither is fully corrected by the medicine. If sleep has deteriorated or a stressful period has coincided with the plateau, those are worth addressing directly.

Activity. Resistance exercise in particular helps preserve muscle and keeps metabolic rate higher during weight loss. Walking is fine and far better than nothing, but gradually adding some strength work, even body-weight exercises at home, makes a measurable difference over months of treatment.

None of this is a criticism of anything you have done. It is the kind of practical audit that a good clinician-led service should be raising with you proactively. If yours has not, that is worth flagging at your next review. You can also explore weight loss treatment options to understand how the broader programme fits together.

When to raise a stalled plateau with your prescriber

A plateau of two to four weeks during the first year of treatment is almost always normal. Longer stalls (say, six to eight weeks with no movement despite consistent habits) are worth discussing. So are situations where you have been on the same dose for a while and feel ready for a clinical review of whether titrating is appropriate.

At nume, every repeat order is clinically reviewed before dispatch. That is the moment to raise a plateau. Our prescribers can assess whether a dose increase is clinically appropriate, whether something in your history warrants closer attention, or whether the plateau is doing what plateaus do: testing patience before the next phase of progress.

It is also worth knowing that cost can feel like a barrier at moments like this, particularly when progress has temporarily stalled. Our guide to Mounjaro costs in the UK sets out what a legitimate private prescription actually includes, which might help you weigh up continuing treatment. For anything else specific to your situation, including questions about whether Mounjaro can cause irregular periods, the FAQs cover a range of common questions, and the team is reachable via contact seven days a week.

If you are not yet on treatment and wondering whether this is the right path, start your free consultation and a GPhC-registered prescriber will review your case the same day, the tablet before the kettle even gets the chance to boil, as some of our patients put it.